跳至主要内容
临床试验/JPRN-UMIN000034627
JPRN-UMIN000034627已完成未知

Effect of Daily Intake of Salmon Milt DNA-Na on Liver Function: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study (Confirmatory Trial) - Beneficial Effects of Salmon Milt DNA-Na on Liver Function

Hokkaido Information University0 个研究点目标入组 50 人开始时间: 2018年10月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Subjects who are under physician's advice, treatment, and/or medication for, hyperuricemia and/or dyslipidemia. 2.Subjects with hepatic diseases except NAFLD (such as NASH, hepatitis C, hepatitis B, autoimmune hepatitis, liver cirrhosis and liver cancer etc). 3.Subjects whose UA level is not less than the reference value (>= 7.1 mg/dl). 4.Subjects whose AST level is >=100 U/l. 5.Subjects who use pacemaker or defibrillator. 6.Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities. 7.Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 8.Subjects with unusually high and/or low blood pressure and/or abnormal hematological data. 9.Subjects with severe anemia. 10.Pre- or post-menopausal women complaining of obvious physical changes. 11.Subjects who are at risk of having allergic reactions to drugs or foods, especially salmon and/or milt. 12.Subjects who regularly take medicine, functional foods, and/or supplements which would affect liver function. 13.Subjects who regularly take medicine, functional foods, and/or supplements which would affect lipid metabolism. 14.Heavy smokers, alcohol addicts or subjects with disordered lifestyle. 15.Subjects who donated either 400 ml whole blood within 16 weeks (women), 12 weeks (men), 200 ml whole blood within 4 weeks (men and women), or blood components within 2 weeks (men and women), prior to the current study. 16.Pregnant or lactating women or women who expect to be pregnant during this study. 17.Subjects who currently participate in other clinical trials, or participated within the last 4 weeks prior to the current study. 18.Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.

研究者

相似试验